-
EP4337672
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4337672
| EP4337672 - PURIFICATION OF SPECIFIC TRIPEPTIDE BY USE OF ETHERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.02.2024 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 29.11.2022 | ||
| Former | unknown Status updated on 11.06.2022 | Most recent event Tooltip | 30.08.2024 | Change - applicant | published on 02.10.2024 [2024/40] | Applicant(s) | For all designated states DSM IP Assets B.V. Wilhelminasingel 39 6221 BE Maastricht / NL | [2024/40] |
| Former [2024/12] | For all designated states DSM IP Assets B.V. Het Overloon 1 6411 TE Heerlen / NL | Inventor(s) | 01 /
HEIDL, Marc 4303 Kaiseraugst / CH | 02 /
SCHAERER, Thomas 4303 Kaiseraugst / CH | 03 /
SCHLIFKE-POSCHALKO, Alexander 4303 Kaiseraugst / CH | [2024/12] | Representative(s) | dsm-firmenich IP Wurmisweg 576 4303 Kaiseraugst / CH | [N/P] |
| Former [2024/12] | dsm-firmenich IP DSM-Firmenich AG Wurmisweg 576 4303 Kaiseraugst / CH | Application number, filing date | 22727095.6 | 03.05.2022 | [2024/12] | WO2022EP61791 | Priority number, date | EP20210172939 | 10.05.2021 Original published format: EP 21172939 | [2024/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022238174 | Date: | 17.11.2022 | Language: | EN | [2022/46] | Type: | A1 Application with search report | No.: | EP4337672 | Date: | 20.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.11.2022 takes the place of the publication of the European patent application. | [2024/12] | Search report(s) | International search report - published on: | EP | 17.11.2022 | Classification | IPC: | C07K1/30, C07K5/083 | [2024/12] | CPC: |
C07K1/30 (EP,US);
A61K8/64 (US);
A61Q19/00 (US);
C07K1/34 (US);
C07K5/081 (EP);
A61K38/00 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/12] | Title | German: | REINIGUNG SPEZIFISCHER TRIPEPTIDE DURCH VERWENDUNG VON ETHERN | [2024/12] | English: | PURIFICATION OF SPECIFIC TRIPEPTIDE BY USE OF ETHERS | [2024/12] | French: | PURIFICATION D'UN TRIPEPTIDE SPÉCIFIQUE AU MOYEN D'ÉTHERS | [2024/12] | Entry into regional phase | 05.10.2023 | National basic fee paid | 05.10.2023 | Designation fee(s) paid | 05.10.2023 | Examination fee paid | Examination procedure | 05.10.2023 | Examination requested [2024/12] | 05.10.2023 | Date on which the examining division has become responsible | 13.06.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]GB1578963 (BASF AG); | [X]WO2010082175 (SEDERMA SA [FR], et al); | [I]WO2012166810 (AMPLIFI BIOTECHNOLOGIES INC [US], et al); | [I]CN107868118 (SHAANXI HUIKANG BIO TECH CO LTD); | [X]WO2020142103 (AVON PROD INC [US]); | [I]WO2020152246 (DSM IP ASSETS BV [NL]); | [I]CN111732628 (ZHEJIANG TIANTAI PHARMACEUTICAL CO LTD, et al) |